
Shivam Autotech Ltd.
Shivam Autotech
₹ 0.00
0.00 (0.00)%
NSE
BSE
Automobile & Ancillaries
Small-cap - With a market cap of ₹2.23 Cr.
| EX-Date | Purpose |
|---|---|
| 09 06 2021 | Right Issue of Equity Shares & Audited Results |
| 13 08 2021 | A.G.M. & Quarterly Results |
| 22 09 2021 | Rights Issue Inter alia, to consider and approve the draft letter of offer and other related matters in connection with the Right Issue of Equity Shares to the existing shareholders of the Company alongwith other business matters. |
| 12 11 2021 | Quarterly Results |
| 25 11 2021 | Rights Issue & Right Issue of Equity Shares |
| 10 12 2021 | Rights Issue A meeting of the Board of Directors of the Company is scheduled to be held on Friday, the 10th day of December, 2021 to postpone the Issue opening date and fix a new issue opening date and accordingly, to consider the other consequential matter thereto. |
| 03 01 2022 | Inter alia, to consider and approve appointment of Chief Financial Officer of the Company |
| 07 02 2022 | Quarterly Results |
| 27 05 2022 | Audited Results |
| 30 05 2022 | Audited Results (Revised) |
| 10 08 2022 | Quarterly Results |
| 22 10 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 27 03 2023 | Inter alia, to consider and approve Intimation of Board Meeting to consider the matter related to Corproate Term Loan pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
| 25 05 2023 | Quarterly Results & Audited Results |
| 02 07 2023 | Inter alia, to consider and approve a proposal issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis and amongst other matters, subject to such regulatory/ statutory approvals as may be required |
| 14 08 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 18 01 2025 | Inter alia, to consider and approve:- (1) To consider various options for raising funds through borrowings including by the way of issuance of Secured, unlisted, redeemable Non-Convertible Debentures by way of private placement/preferential allotment Basis or any other mode as decided by the Board of Directors on the prevailing market conditions and felt need of the company. |
| 22 01 2025 | Rights Issue & Inter alia, to consider and approve:- 1. Increase in the Authorised Share Capital of the Company. 2. Consider the proposal for raising funds. 3. Constitution of a special committee of the Board of Directors. |
| 07 02 2025 | Quarterly Results |
| 20 02 2025 | Inter alia, to consider and approve:- 1. allotment of equity shares pursuant to exercise of option attached to 250 Optionally Convertible Debentures (OCDs) having a face value of ?10,00,000/- each by India Credit Opportunities Fund II, option holder. 2. Any other businesses with the permission of the Chairperson |
| 13 03 2025 | Inter alia, to consider and approve the proposal of availing Corporate term loan facility for business requirements |
| 12 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 21 10 2025 | Raising Funds |
| 12 11 2025 | Quarterly Results |
| 26 11 2025 | Inter alia, to consider, and if deemed appropriate, approve the following matters: 1. Amendments/modifications to the Articles of Association of the Company in such manner as may be deemed fit, subject to the approval of the shareholders of the Company by way of a special resolution. 2. Proposals for fund raising of up to such amount as decided by the Board of Directors by way of issue of non-convertible debentures, optionally convertible debentures and/or any other securities as decided by the Board of Directors, either in a single tranche or in multiple tranches, through preferential issue and/or any other method as decided by the Board of Directors, subject to compliance with the provisions of the Companies Act, 2013 and the rules prescribed thereunder, applicable regulations prescribed by the Securities and Exchange Board of India and any other applicable laws, and receipt of requisite statutory/regulatory approvals (including the approval of the shareholders of the Company, if and to the extent required) and third-party consents (if and to the extent required). 3. Any other matter(s) as the Board of Directors may propose, discuss and put to vote with the permission of the Chairperson. |
| 29 11 2025 | Fund raising |
| 04 02 2026 | Quarterly Results |
